PTK2 and cancer: Considering these findings, we propose determining the potential regulatory effect of triazaspirane derivatives with spiro-hydantoin-based structure (TRI-BE) on the mechanisms of biological activity in cancer cells and elucidating their possible association with the FAK/Src signaling pathway involved in the development of cancer [15,22].